levofloxacin has been researched along with warfarin in 35 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 36,573 | 2,143 | 14,728 |
Protein | Taxonomy | levofloxacin (IC50) | warfarin (IC50) |
---|---|---|---|
Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 21 (60.00) | 29.6817 |
2010's | 12 (34.29) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
Fowler, C; Liao, S; Nayak, RK; Palmer, M | 1 |
Locke, C; Ravnan, SL | 1 |
Cinetto, L; Gheno, G | 1 |
Fugate, SE; Jones, CB | 1 |
Burrows, MM; Enlow, AM; Greenwood, MC; Kilpatrick, DM; Lower, DL; Yamreudeewong, W | 1 |
Fugit, RV; Glasheen, JJ; Prochazka, AV | 2 |
Anderson, HG; McCall, KL; Scott, JC | 1 |
Bell, CM; Kopp, A; Mamdami, MM; Stroud, LF | 1 |
Cole, J; Mathews, S; Ryono, RA | 1 |
Glasheen, JJ; Prochazka, AV | 2 |
Ismail, HM; Smalligan, RD; Vadlamudi, RS | 1 |
Ahmed, A; Fay, WP; Kaus, CA; Stephens, JC | 1 |
Carroll, DG; Carroll, DN | 1 |
Gracia García, B; Jodar Masanés, R; Leiva Badosa, E; Mercadal Orfila, G; Perayre Badía, M; Reynaldo Martínez, C | 1 |
Abe, Y; Ikegami, Y; Nemoto, C; Shimada, J; Tase, C; Tsukada, Y | 1 |
Bomgaars, LR; Kim, S; Moffett, BS | 1 |
Chen, H; Li, H; Lin, J; Liu, X; Xu, S; Xu, Y; Yuan, Z | 1 |
2 review(s) available for levofloxacin and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Interactions between warfarin and three commonly prescribed fluoroquinolones.
Topics: Aza Compounds; Ciprofloxacin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Humans; International Normalized Ratio; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Warfarin | 2008 |
3 trial(s) available for levofloxacin and warfarin
Article | Year |
---|---|
Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Anticoagulants; Blood Coagulation; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Humans; Levofloxacin; Liver; Male; Ofloxacin; Warfarin | 1996 |
Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Blood Coagulation; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; International Normalized Ratio; Levofloxacin; Male; Middle Aged; Ofloxacin; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 2008 |
Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge.
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Asian; Cardiac Surgical Procedures; Child; Child, Preschool; Citalopram; Female; Hospital Information Systems; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Patient Readmission; Postoperative Hemorrhage; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; Warfarin | 2013 |
30 other study(ies) available for levofloxacin and warfarin
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
Levofloxacin and warfarin interaction.
Topics: Aged; Anti-Infective Agents; Anticoagulants; Blood Coagulation; Drug Interactions; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Warfarin | 2001 |
Levofloxacin-warfarin interaction.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Anticoagulants; Drug Interactions; Female; Follow-Up Studies; Hemorrhage; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Warfarin | 2001 |
Levofloxacin and warfarin interaction.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Drug Administration Schedule; Drug Synergism; Female; Humans; International Normalized Ratio; Levofloxacin; Male; Middle Aged; Ofloxacin; Prothrombin Time; Warfarin | 2002 |
Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy.
Topics: Aged; Aged, 80 and over; Drug Interactions; Drug Therapy, Combination; Female; Hospitals, Veterans; Humans; International Normalized Ratio; Levofloxacin; Male; Middle Aged; Ofloxacin; Warfarin | 2003 |
Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment.
Topics: Anticoagulants; Drug Interactions; Drug Therapy, Combination; Humans; International Normalized Ratio; Levofloxacin; Ofloxacin; Warfarin | 2003 |
Retrospective evaluation of a possible interaction between warfarin and levofloxacin.
Topics: Aged; Body Temperature; Data Collection; Drug Administration Schedule; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Felodipine; Female; Humans; International Normalized Ratio; Levofloxacin; Male; Medical Records; Middle Aged; Ofloxacin; Outpatients; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Treatment Outcome; Warfarin | 2005 |
The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Anticoagulants; Azithromycin; Cohort Studies; Drug Interactions; Female; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Platelet Aggregation Inhibitors; Prazosin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 2005 |
The safety of levofloxacin in elderly patients on warfarin.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Case-Control Studies; Drug Interactions; Female; Hemorrhage; Humans; Levofloxacin; Male; Odds Ratio; Ofloxacin; Ontario; Thrombosis; Warfarin | 2005 |
Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
Topics: Aged; Anticoagulants; Databases as Topic; Drug Monitoring; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Hospitals, Veterans; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; United States; Warfarin | 2006 |
The safety of levofloxacin in patients on warfarin.
Topics: Anti-Bacterial Agents; Anticoagulants; Drug Interactions; Hemorrhage; Humans; International Normalized Ratio; Levofloxacin; Ofloxacin; Thrombosis; Warfarin | 2007 |
Interaction between warfarin and levofloxacin: case series.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Drug Interactions; Female; Hemorrhage; Humans; Levofloxacin; Male; Ofloxacin; Pericardial Effusion; Retroperitoneal Space; Warfarin | 2007 |
Further evidence of a clinically significant levofloxacin-warfarin interaction.
Topics: Anti-Bacterial Agents; Anticoagulants; Drug Interactions; Hemorrhage; Humans; International Normalized Ratio; Levofloxacin; Ofloxacin; Risk Factors; Warfarin | 2008 |
Retrospective assessment of potential interaction between levofloxacin and warfarin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Biomarkers; Drug Interactions; Female; Humans; Inpatients; International Normalized Ratio; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies; Time Factors; Warfarin | 2009 |
Acute renal failure caused by severe coagulopathy induced by the interaction between warfarin potassium and levofloxacin: a case report.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anticoagulants; Blood Coagulation Disorders; Cardiomyopathy, Dilated; Drug Interactions; Hematuria; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Shock; Urinary Tract Infections; Warfarin | 2012 |
Light-Triggered Fluorescence Self-Reporting Nitric Oxide Release from Coumarin Analogues for Accelerating Wound Healing and Synergistic Antimicrobial Applications.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Movement; Cell Proliferation; Coumarins; Drug Synergism; Female; Fluorescence; Human Umbilical Vein Endothelial Cells; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Donors; Wound Healing | 2022 |